Search alternatives:
significantly improve » significantly improved (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search), improves disease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 81 - 100 results of 18,658 for search '(( significantly ((a decrease) OR (linear decrease)) ) OR ( significantly improve decrease ))', query time: 0.33s Refine Results
  1. 81
    The significance of the specific Nusselt number on a variety of factor.

    The significance of the specific Nusselt number on a variety of factor. by Siva Sankari (2827295)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 82
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  3. 83
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  4. 84
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  5. 85
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  6. 86
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  7. 87
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  8. 88
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  9. 89
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  10. 90
    Table 1_NSAID use may decrease serum Klotho levels.docx

    Table 1_NSAID use may decrease serum Klotho levels.docx by Jingchao Yan (14079168)

    Published 2025
    “…Subgroup analyses did not reveal any statistically significant interactions.</p>Conclusion<p>Contrary to previous speculations, the use of NSAIDs is associated with a decrease in serum Klotho levels.…”
    Save to List
    Saved in:
  11. 91
    Sensory-evoked potentials of N80 and N150.

    Sensory-evoked potentials of N80 and N150. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 92
    Compression index of improved red clay.

    Compression index of improved red clay. by Quan Shen (37564)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 93
    Compressibility modulus of improved red clay.

    Compressibility modulus of improved red clay. by Quan Shen (37564)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    Compressive strain of improved red clay.

    Compressive strain of improved red clay. by Quan Shen (37564)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    General procedure for the synthesis of A and A-c1.

    General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 96
    Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3.

    Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 97
    Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction.

    Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 98
    Difference in (a) IL-17, and (b) TNF-α relative gene expression levels between baseline and six months after treatment using systemic and local antibiotic treatment.

    Difference in (a) IL-17, and (b) TNF-α relative gene expression levels between baseline and six months after treatment using systemic and local antibiotic treatment. by Iva Milinkovic (22331710)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 99
    Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia.

    Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. by Wenbin Wu (292223)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 100
    Microstructure of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3.

    Microstructure of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: